weight loss drugs that are not glp 1 GLP-1: Genetic Variants Related to GLP-1 RA Medications Weight loss drugs don't work

Our patients at Centra Internal Medicine noticed modest weight reduction within the first four weeks of treatment

Flockhart M, Nilsson LC, Tais S, Ekblom B, Apro W, Larsen FJ

Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: a Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants

Many commercial health plans and employer-sponsored benefit programs either exclude anti-obesity medications from formularies entirely or place them on higher cost-sharing tiers, resulting in limited or no insurance coverage for patients, even when clinically appropriate

For example, 88 percent of cardiologists surveyed said that they had prescribed GLP-1RAs to treat cardiovascular disease

employers and employees billions each year